Free Trial
NASDAQ:AHCO

AdaptHealth (AHCO) Stock Price, News & Analysis

AdaptHealth logo
$10.16 +0.06 (+0.59%)
Closing price 06/12/2026 04:00 PM Eastern
Extended Trading
$10.30 +0.15 (+1.43%)
As of 06/12/2026 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About AdaptHealth Stock (NASDAQ:AHCO)

Advanced

Key Stats

Today's Range
$10.10
$10.28
50-Day Range
$9.65
$13.38
52-Week Range
$8.06
$13.43
Volume
769,311 shs
Average Volume
1.09 million shs
Market Capitalization
$1.38 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$14.29
Consensus Rating
Moderate Buy

Company Overview

AdaptHealth Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
98th Percentile Overall Score

AHCO MarketRank™: 

AdaptHealth scored higher than 98% of companies evaluated by MarketBeat, and ranked 20th out of 862 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    AdaptHealth has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on no strong buy ratings, 5 buy ratings, 2 hold ratings, and 1 sell rating.

  • Upside Potential

    AdaptHealth has a consensus price target of $14.29, representing about 40.6% upside from its current price of $10.16.

  • Amount of Analyst Coverage

    AdaptHealth has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about AdaptHealth's stock forecast and price target.
  • Earnings Growth

    Earnings for AdaptHealth are expected to grow by 140.91% in the coming year, from $0.44 to $1.06 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of AdaptHealth is -16.39, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of AdaptHealth is -16.39, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Growth Ratio

    AdaptHealth has a PEG Ratio of 0.52. PEG Ratios below 1 indicate that a company could be undervalued.

  • Price to Book Value per Share Ratio

    AdaptHealth has a P/B Ratio of 0.90. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about AdaptHealth's valuation and earnings.
  • Percentage of Shares Shorted

    5.66% of the float of AdaptHealth has been sold short.
  • Short Interest Ratio / Days to Cover

    AdaptHealth has a short interest ratio ("days to cover") of 6.94.
  • Change versus previous month

    Short interest in AdaptHealth has recently increased by 4.92%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    AdaptHealth does not currently pay a dividend.

  • Dividend Growth

    AdaptHealth does not have a long track record of dividend growth.

  • News Sentiment

    AdaptHealth has a news sentiment score of 1.01. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.85 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for AdaptHealth this week, compared to 3 articles on an average week.
  • Search Interest

    Only 6 people have searched for AHCO on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • MarketBeat Follows

    3 people have added AdaptHealth to their MarketBeat watchlist in the last 30 days.
  • Net Insider Buying

    Over the last three months, insiders have purchased a net $4,324,561.00 in company stock, which represents 0.3132% of the company's market cap.

  • Insider Buying vs. Insider Selling

    In the past three months, AdaptHealth insiders have bought 3,812.67% more of their company's stock than they have sold. Specifically, they have bought $4,437,987.00 in company stock and sold $113,426.00 in company stock.

  • Percentage Held by Insiders

    1.95% of the stock of AdaptHealth is held by insiders.

  • Percentage Held by Institutions

    82.67% of the stock of AdaptHealth is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about AdaptHealth's insider trading history.
Receive AHCO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AdaptHealth and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

AHCO Stock News Headlines

DOJ Admits It In Court—Your Cash Can Be Seized Without Warning
The Department of Justice recently argued in court that cash may not be legally your property - raising concerns about government authority to freeze or seize private accounts. Greece raided pensions. Cyprus drained bank accounts. Poland seized retirement funds. Priority Gold has put together a free Wealth Defense Guide for Americans looking to move assets beyond potential government reach.tc pixel
See More Headlines

AHCO Stock Analysis - Frequently Asked Questions

AdaptHealth's stock was trading at $9.96 at the beginning of 2026. Since then, AHCO stock has increased by 2.0% and is now trading at $10.16.

AdaptHealth Corp. (NASDAQ:AHCO) announced its earnings results on Tuesday, May, 5th. The company reported ($0.12) earnings per share for the quarter, missing the consensus estimate of $0.01 by $0.13. The company's revenue for the quarter was up 5.4% compared to the same quarter last year.
Read the conference call transcript
.

Top institutional investors of AdaptHealth include Dimensional Fund Advisors LP (5.09%), Segall Bryant & Hamill LLC (2.56%), Principal Financial Group Inc. (2.05%) and Lazard Asset Management LLC (1.23%). Insiders that own company stock include Skyknight Aero Holdings, Llc, Shaw Rietkerk, Jason A Clemens, Albert A Prast, Russell E Schuster III and David Solomon Williams III.
View institutional ownership trends
.

Shares of AHCO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that AdaptHealth investors own include Waste Connections (WCN), AUO (AUOTY), American Water Works (AWK), DiamondRock Hospitality (DRH), The RMR Group (RMR), iShares Micro-Cap ETF (IWC) and Triple Flag Precious Metals (TFPM).

Company Calendar

Last Earnings
5/05/2026
Today
6/14/2026
Next Earnings (Estimated)
8/04/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Healthcare
Current Symbol
NASDAQ:AHCO
CIK
1725255
Fax
N/A
Employees
10,900
Year Founded
2012

Price Target and Rating

High Price Target
$18.00
Low Price Target
$11.00
Potential Upside/Downside
+40.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
8 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.62)
Trailing P/E Ratio
N/A
Forward P/E Ratio
23.09
P/E Growth
0.52
Net Income
-$70.79 million
Net Margins
-2.42%
Pretax Margin
-0.91%
Return on Equity
2.76%
Return on Assets
0.99%

Debt

Debt-to-Equity Ratio
1.21
Current Ratio
0.92
Quick Ratio
0.71

Sales & Book Value

Annual Sales
$3.24 billion
Price / Sales
0.43
Cash Flow
$4.18 per share
Price / Cash Flow
2.43
Book Value
$11.27 per share
Price / Book
0.90

Miscellaneous

Outstanding Shares
135,910,000
Free Float
133,265,000
Market Cap
$1.38 billion
Optionable
Optionable
Beta
1.47

Social Links

The 7 Hottest IPOs On Wall Street’s 2026 Watchlist Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

This page (NASDAQ:AHCO) was last updated on 6/14/2026 by MarketBeat.com Staff.
From Our Partners